Found: 21
Select item for more details and to access through your institution.
Recent research trends and updates on nonalcoholic fatty liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 1, doi. 10.3350/cmh.2018.0037
- By:
- Publication type:
- Article
Pathologic differential diagnosis of metastatic carcinoma in the liver.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 12, doi. 10.3350/cmh.2018.0067
- By:
- Publication type:
- Article
Radiomics and radiogenomics of primary liver cancers.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 21, doi. 10.3350/cmh.2018.1007
- By:
- Publication type:
- Article
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 30, doi. 10.3350/cmh.2018.0061
- By:
- Publication type:
- Article
Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 37, doi. 10.3350/cmh.2018.1011
- By:
- Publication type:
- Article
Can hepatic steatosis really promote hepatitis B viral hepatocarcinogenesis? The jury is out on.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 40, doi. 10.3350/cmh.2018.0101
- By:
- Publication type:
- Article
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillarassociated protein 4 in hepatitis C patients.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 42, doi. 10.3350/cmh.2018.0029
- By:
- Publication type:
- Article
Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 52, doi. 10.3350/cmh.2018.0040
- By:
- Publication type:
- Article
Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 65, doi. 10.3350/cmh.2018.0070
- By:
- Publication type:
- Article
Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 74, doi. 10.3350/cmh.2018.0072
- By:
- Publication type:
- Article
Biochemical profile in an infant with neonatal hemochromatosis shows evidence of impairment of mitochondrial long-chain fatty acid oxidation.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 86, doi. 10.3350/cmh.2018.0005
- By:
- Publication type:
- Article
Pathologic differential diagnosis of metastatic carcinoma in the liver.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 12, doi. 10.3350/cmh.2018.0067
- By:
- Publication type:
- Article
Radiomics and radiogenomics of primary liver cancers.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 21, doi. 10.3350/cmh.2018.1007
- By:
- Publication type:
- Article
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 30, doi. 10.3350/cmh.2018.0061
- By:
- Publication type:
- Article
Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 37, doi. 10.3350/cmh.2018.1011
- By:
- Publication type:
- Article
Can hepatic steatosis really promote hepatitis B viral hepatocarcinogenesis? The jury is out on.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 40, doi. 10.3350/cmh.2018.0101
- By:
- Publication type:
- Article
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillarassociated protein 4 in hepatitis C patients.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 42, doi. 10.3350/cmh.2018.0029
- By:
- Publication type:
- Article
Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 52, doi. 10.3350/cmh.2018.0040
- By:
- Publication type:
- Article
Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 65, doi. 10.3350/cmh.2018.0070
- By:
- Publication type:
- Article
Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 74, doi. 10.3350/cmh.2018.0072
- By:
- Publication type:
- Article
Biochemical profile in an infant with neonatal hemochromatosis shows evidence of impairment of mitochondrial long-chain fatty acid oxidation.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 86, doi. 10.3350/cmh.2018.0005
- By:
- Publication type:
- Article